FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approves a supplemental application for Bupropion hydrochloride (ANDA 076143) submitted by BluePoint Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Seasonal Affective Disorder
• Tobacco Use Disorder

Drugs mentioned

• Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)